BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
Latest, FY2025
4,548
Period ended Dec 31, 2025
Change on a year earlier
+72.3%
2,639 in FY2024
History
13 years
Since FY2013
Sources
9
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cash and cash equivalents ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,548 | +72.3% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 2,639 | -16.8% | Form 10-Q (filed 2026-05-06) ↗ |
| FY2023 | Dec 31, 2023 | 3,172 | -18.1% | Form 10-K (filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 3,875 | -11.6% | Form 10-K (filed 2026-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 4,383 | +215.3% | Form 10-K (filed 2025-02-27) ↗ |
| FY2020 | Dec 31, 2020 | 1,390 | +123.9% | Form 10-K (filed 2024-02-26) ↗ |
| FY2019 | Dec 31, 2019 | 621 | -16.2% | Form 10-K (filed 2023-02-27) ↗ |
| FY2018 | Dec 31, 2018 | 741 | +209.1% | Form 10-K (filed 2022-02-28) ↗ |
| FY2017 | Dec 31, 2017 | 240 | +173.8% | Form 10-K (filed 2018-02-28) ↗ |
| FY2016 | Dec 31, 2016 | 87.5 | +388.8% | Form 10-K (filed 2017-03-22) ↗ |
| FY2015 | Dec 31, 2015 | 17.9 | +28.8% | Form 10-Q (filed 2016-05-12) ↗ |
| FY2014 | Dec 31, 2014 | 13.9 | +256.4% | Form 10-K (filed 2018-02-28) ↗ |
| FY2013 | Dec 31, 2013 | 3.90 | – | Form 10-K (filed 2017-03-22) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Cash and cash equivalents ($M) ($M), annual FY2013–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_cash
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.